Eric

Phynd Technologies, Inc., a leading provider information management platform, today announced it has completed a Series B funding round of more than $8 million. Participating investors include the MemorialCare Innovation Fund, more »

Ivantis, a company dedicated to developing new and innovative solutions for glaucoma, announced today that it received Food and Drug Administration (FDA) approval for the Hydrus® Microstent, a microinvasive glaucoma more »

Patients with primary open-angle glaucoma who received a Schlemm’s canal microstent combined with phacoemulsification demonstrated a superior reduction in IOP and medication use compared with those who received phaco alone, more »

AutoGenomics, Inc., based in Carlsbad, CA, announced that its INFINITI® Neural Response Panel has been granted designation as a Breakthrough Device by the US Food and Drug Administration (FDA). The more »

AutoGenomics, Inc., announced that INFINITI Neural Response Panel has been granted designation, by the US Food and Drug Administration (FDA), as a breakthrough device. The panel is a qualitative in more »

AutoGenomics said today that its Infiniti Neural Response Panel — a genomic test that gauges risk for opioid dependency — has been granted designation as a breakthrough device by the more »

For many years, staff and clinicians at the Hospital for Special Surgery in Manhattan have used pagers to communicate. But over time the limitations of pagers became clear, said Nick more »

2018 HIMSS Conference and Exhibition—An Apple Watch messaging notification app, Round Robin scheduling and advanced patient-centered care team access are PerfectServe’s® newest capabilities unveiled today at the Healthcare Information and more »

KNOXVILLE, Tenn., – PerfectServe®, healthcare’s most comprehensive and secure clinical communication and collaboration platform, announced today a strategic integration with AMiON®, a physician scheduling software solution for groups, hospitals and more »